CVS Health Corp. (CVS) is currently at $77.04, up $3.35 or 4.54%
— Would be highest close since Oct. 10, 2018, when it closed at $78.92
— On pace for largest percent increase since Aug. 2, 2016, when it rose 4.89%
— Earlier Tuesday, CVS reported third-quarter revenue rose 2.4% to $47.3 billion, beating the $47.2 billion analysts polled by Refinitiv were expecting. The company posted a profit of $1.39 billion, or $1.36 a share, up from $1.29 billion, or $1.26 a share, a year earlier. Excluding one-time items, adjusted earnings were $1.73 a share, ahead of the consensus forecast of $1.71 a share. For 2018, CVS reaffirmed its guidance for adjusted earnings per share of $6.98 to $7.08
— Up 6.26% year-to-date; on pace for best year since 2014 when it rose 34.57%
— Down 32.1% from its all-time closing high of $113.45 on July 29, 2015
— Up 11.73% from 52 weeks ago (Nov. 7, 2017), when it closed at $68.95
— Down 7.89% from its 52-week closing high of $83.63 on Jan. 29, 2018
— Up 27.12% from its 52-week closing low of $60.60 on March 27, 2018
— Traded as high as $77.05; highest intraday level since Oct. 11, 2018, when it hit $77.07
— Up 4.56% at today’s intraday high; largest intraday percent increase since Aug. 8, 2018, when it rose as much as 6.02%
— Eighth best performer in the S&P 500 today
